Analyzing Google Search Trends for Migraine Surgery and Nurtec in Response to Public Announcements.

Autor:	Bishay AE; From Vanderbilt University School of Medicine, Nashville, Tenn., Fijany AJ; Department of General Surgery, Vanderbilt University Medical Center, Nashville, Tenn., Holan C; Department of Plastic Surgery, Mayo Clinic, Rochester, Minn., Mubang RN; Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tenn., Montorfano L; Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tenn., Olsson SE; Anne Burnett Marion School of Medicine, Texas Christian University, Fort Worth, Tex., Troia T; Anne Burnett Marion School of Medicine, Texas Christian University, Fort Worth, Tex., Bakian A; University of Southern California, Los Angeles, Calif., Kassis SA; Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tenn., Tran BV; Department of Plastic Surgery, Mayo Clinic, Rochester, Minn.
Jazyk:	angličtina
Zdroj:	Plastic and reconstructive surgery. Global open [Plast Reconstr Surg Glob Open] 2024 Jul 18; Vol. 12 (7), pp. e5996. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
DOI:	10.1097/GOX.0000000000005996
Abstrakt:	Background: Nurtec, a versatile migraine medication, has gained popularity. However, the awareness of migraine surgery remains uncertain. Methods: Following a descriptive approach, this cross-sectional study used Google Trends data as of December 1, 2023, to analyze internet search patterns. Approval from Vanderbilt University's institutional review board and adherence to Strengthening the Reporting of Observational Studies in Epidemiology guidelines were confirmed. Monthly relative search volume (RSV) data for "migraine surgery," "Nurtec," and "Rimegepant" were collected from January 1, 2004, to November 11, 2023, within the United States. Statistical analysis involved determining mean monthly RSV values and percentage changes for critical periods. Results: For "Nurtec," a significant surge in RSV occurred from March 2020 to April 2020 (344%). Additional peaks were observed from June 2020 to July 2020 (66%), October 2020 to December 2020 (169%), May 2021 to June 2021 (33%), and May 2023 to June 2023 (14%). "Migraine surgery" exhibited a notable 400% increase in RSV, from March 2005 to May 2005. However, post-2006, RSV for "migraine surgery" consistently remained low without noticeable peaks. Conclusions: The analysis of RSV trends for "Nurtec" and "migraine surgery" from 2004 to 2023 reveals the impact of pivotal events and marketing strategies on public interest. The distinct peaks in "Nurtec" RSV align with Food & Drug Administration approvals and marketing campaigns, highlighting the medication's accessibility. Conversely, the consistently low RSV for "migraine surgery" indicates limited awareness, emphasizing the need for enhanced promotion and education regarding surgical interventions. Competing Interests: The authors have no financial interest to declare in relation to the content of this article. Texas Christian University Open Access Fund 2023–2024 supported this article’s open access publishing fee. (Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu